Overview

Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy, safety and tolerability of topically administered diclofenac gel versus placebo with respect to the symptom score (pain, temperature and size of erythema along the superficial vein)
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Diclofenac